Published • loading... • Updated
CVS Caremark to Cover Zepbound Again After Lawsuit, Widespread Backlash
CVS said the move will give 25 million to 30 million Americans more access to weight-loss drugs and could cut costs by 10% to 15%.
- On Thursday, CVS Caremark announced it will restore coverage of Eli Lilly and Company's Zepbound by October 1, 2026, and add the drugmaker's new obesity pill, Foundayo, starting June 1, 2026.
- The move reverses a July 1, 2025 decision when CVS Caremark dropped Zepbound from coverage after striking a deal with competitor Novo Nordisk to make Wegovy the preferred obesity treatment.
- Eligible patients with commercial coverage may pay as low as $25 a month, while Medicare Part D beneficiaries may be eligible for $50 monthly costs beginning July 1, 2026.
- The addition positions Lilly and Novo as co-preferred options on CVS's standard formulary, with CVS expecting the move to drive 10% to 15% additional savings across the weight management category.
- Employers retain final authority to decide whether to cover GLP-1 weight-loss drugs for members, even as a class-action lawsuit challenging the previous coverage removal remains active.
Insights by Ground AI
18 Articles
18 Articles
CVS Returns Zepbound to Drug Plans After Lilly Slashes Price
More than 10 million US patients will regain easy access to Eli Lilly & Co.’s obesity shot Zepbound through insurance after CVS Health Corp. reversed a controversial decision to restrict it for certain drug plans.
·New York, United States
Read Full Article
Pharmalittle: We're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more
Top of the morning to you. And a fine one it is here at the Pharmalot campus, where the official mascots are quietly snoozing now that our shortest person has returned to her out-of-town studies. As for us, we are downing another cup of stimulation — blueberry cobbler is our preference today. Feel free to join us. As always, here are your tidbits. Hope your day goes well and you conquer the world. And of course, do stay in touch. … The public is…
·Boston, United States
Read Full ArticleCoverage Details
Total News Sources18
Leaning Left5Leaning Right0Center11Last UpdatedBias Distribution69% Center
Bias Distribution
- 69% of the sources are Center
69% Center
L 31%
C 69%
Factuality
To view factuality data please Upgrade to Premium
